Chronic inflammatory polyneuropathy revealing malignant melanoma [2]

Journal of Neuro-Oncology

Volumn 71, Issue 3, 2005, Pages 335-336

  Rousseau, A ^a   Salachas, F ^a   Baccard, M ^b   Delattre, J Y ^a   Sanson, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AMELANOTIC MELANOMA; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INGUINAL LYMPH NODE; LETTER; LYMPHADENOPATHY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PROTEIN CEREBROSPINAL FLUID LEVEL; SKIN BIOPSY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; FOOT; HUMANS; IMMUNOGLOBULINS; MALE; MELANOMA; PARESTHESIA; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 14944373231     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-1871-3     Document Type: Letter

References (9)

1. SJ Bird MJ Brown ME Shy SS Scherer 1996 Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma Neurology 46 822-824
2. MD Weiss CA Luciano C Semino-Mora MC Dalakas RH Quarles 1998 Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma Neurology 51 1738-1741
3. DA Anthoney I Bone TRJ Evans 2000 Inflammatory demyelinating polyneuropathy: A complication of immunotherapy in malignant melanoma Ann Oncol 11 1197-1200
4. AB Noronha JR Harper AA Ilyas RA Reisfeld RH Quarles 1986 Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells J Neurochem 47 1558-1565
5. GN Fuller JM Spies JD Pollard JG McLeod 1994 Demyelinating neuropathies triggered by melanoma immunotherapy Neurology 44 2404-2405
6. MN Saleh MB Khazaeli RH Wheeler E Dropcho T Liu M Urist DM Miller S Lawson M Dixon CH Russell AF LoBuglio 1992 Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma Cancer Res 52 4342-4347
7. N Yuki M Yamada Y Tagawa H Takahashi S Handa 1997 Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy J Neurol Sci 149 127-130
8. P Duhra A Ilchyshyn 1991 Prolonged survival in metastatic malignant melanoma associated with vitiligo Clin Exp Dermatol. 16 303-305
9. C Yee JA Thompson P Roche DR Byrd PP Lee M Piepkorn K Kenyon MM Davis SR Riddell PD Greenberg 2000 Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo J Exp Med 192 1637-1644